ASAM Level 3.7 and 3.5 Residential Billing — 2026
ASAM Level 3.7 (Medically Monitored Intensive Inpatient) and Level 3.5 (Clinically Managed High-Intensity Residential) are the two most-denied SUD residential levels of care. Commercial payer denials on ASAM 3.7/3.5 are frequently MHPAEA parity violations.
The 2026 Denial Pattern
- Commercial payer denies day 5-14 of ASAM 3.7 stay claiming lower level appropriate
- No clinical criteria review; automated denial based on stay length
- Peer-to-peer requested but scheduled 2-3 weeks out
- Client discharged AMA due to payer denial before appeal completes
MHPAEA Parity Position
Med/surg parallel: A cardiac patient at similar acuity would not face automated stay-length denial without clinical review. ASAM 3.7 stay-length denial is a Non-Quantitative Treatment Limitation (NQTL) violating 2024 MHPAEA Final Rule.
Appeal Framework — Same-Day Peer-to-Peer
- Escalate denial to compliance officer within 24 hours
- Request expedited peer-to-peer citing parity
- If P2P denied, escalate to state DOI parity complaint
- Concurrent MHPAEA parity appeal in writing
Recovery Benchmark
ASAM 3.7 denial recovery typically returns $200K-$500K/yr for multi-site SUD residential operators.
Case Study
Free 30-day ASAM audit · Pricing 4-8%
– KD, Revenant Care